These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3604469

  • 1. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis).
    Ikeda N, Umetsu K, Suzuki T.
    Z Rechtsmed; 1987; 98(2):141-6. PubMed ID: 3604469
    [Abstract] [Full Text] [Related]

  • 2. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.
    Levitt L, Pearson RW.
    JAMA; 1980 Mar 28; 243(12):1262-3. PubMed ID: 7359684
    [No Abstract] [Full Text] [Related]

  • 3. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
    Klein SM, Khan MA.
    J Rheumatol; 1983 Jun 28; 10(3):512-3. PubMed ID: 6224935
    [Abstract] [Full Text] [Related]

  • 4. Stevens-Johnson syndrome due to sulindac: a case report and review of the literature.
    Maguire FW.
    Del Med J; 1981 Apr 28; 53(4):193-7. PubMed ID: 7227578
    [No Abstract] [Full Text] [Related]

  • 5. Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.
    Husain Z, Runge LA, Jabbs JM, Hyla JA.
    J Rheumatol; 1981 Apr 28; 8(1):176-9. PubMed ID: 7218253
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N, Bastuji-Garin S, Mockenhaupt M, Roujeau JC, Flahault A, Kelly JP, Martin E, Kaufman DW, Maison P.
    Pediatrics; 2009 Feb 28; 123(2):e297-304. PubMed ID: 19153164
    [Abstract] [Full Text] [Related]

  • 15. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W, Stingl G, Wolff K.
    Hautarzt; 1982 Sep 28; 33(9):484-90. PubMed ID: 7174320
    [Abstract] [Full Text] [Related]

  • 16. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M.
    Expert Rev Clin Immunol; 2011 Nov 28; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [Abstract] [Full Text] [Related]

  • 17. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B, Mockenhaupt M, Baur S, Stocker U, Schöpf E.
    Hautarzt; 1993 Aug 28; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract] [Full Text] [Related]

  • 18. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
    Huang LY, Liao WC, Chiou CC, Lou JP, Hu P, Ko FC.
    J Formos Med Assoc; 2007 Dec 28; 106(12):1032-7. PubMed ID: 18194909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.